2G01
Pyrazoloquinolones as Novel, Selective JNK1 inhibitors
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 17-ID |
Synchrotron site | APS |
Beamline | 17-ID |
Temperature [K] | 110 |
Detector technology | CCD |
Collection date | 2004-10-18 |
Detector | ADSC QUANTUM 4 |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 150.622, 150.622, 118.996 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 19.890 - 3.500 |
R-factor | 0.286 |
Rwork | 0.283 |
R-free | 0.35400 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1jnk JNK3 KINASE |
RMSD bond length | 0.008 |
RMSD bond angle | 1.400 |
Data reduction software | SDMS |
Data scaling software | HKL-2000 |
Phasing software | CNX |
Refinement software | CNX (2002) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 3.620 |
High resolution limit [Å] | 3.500 | 3.500 |
Rmerge | 0.065 | 0.365 |
Number of reflections | 15793 | |
<I/σ(I)> | 27.9 | 2.6 |
Completeness [%] | 81.7 | 63.7 |
Redundancy | 5.8 | 5.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6.2 | 277 | Protein was preincubated with the JIP1 peptide at a 5x molar excess. Protein concentration 9-12.6 mg/mL. Hanging drops consisted of 2uL protein plus 2uL well solution over 1 mL of well solution. Well solution: 2.8-3.1 M Ammonium Sulfate, 10-14% glycerol. For Co-crystallization experiment compound was dissolved in DMSO at 100 mM concentration. Allow to incubate for at least an hour on ice. Solution was spun for 5 minutes at 2000g prior to setting up for crystallization. , pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K |